Ratio Review: Analyzing Microbot Medical Inc (MBOT)’s Price-to-Cash and Price-to-Free Cash Flow

Abby Carey

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

After finishing at $1.73 in the prior trading day, Microbot Medical Inc (NASDAQ: MBOT) closed at $1.83, up 5.78%. In other words, the price has increased by $5.78 from its previous closing price. On the day, 1.83 million shares were traded. MBOT stock price reached its highest trading level at $1.83 during the session, while it also had its lowest trading level at $1.7.

Ratios:

Our goal is to gain a better understanding of MBOT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.53 and its Current Ratio is at 27.53. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In the most recent recommendation for this company, H.C. Wainwright on January 13, 2020, Reiterated its Buy rating but revised its target price to $26 from $12 previously.

On December 24, 2019, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $10 to $12.

On January 31, 2018, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $1.75.Ladenburg Thalmann initiated its Buy rating on January 31, 2018, with a $1.75 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBOT now has a Market Capitalization of 122899232 and an Enterprise Value of 43640220.

Stock Price History:

The Beta on a monthly basis for MBOT is 1.26, which has changed by 0.8484849 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, MBOT has reached a high of $4.67, while it has fallen to a 52-week low of $0.89. The 50-Day Moving Average of the stock is -31.24%, while the 200-Day Moving Average is calculated to be -26.99%.

Shares Statistics:

The stock has traded on average 4.27M shares per day over the past 3-months and 1821270 shares per day over the last 10 days, according to various share statistics. A total of 67.16M shares are outstanding, with a floating share count of 67.02M. Insiders hold about 0.20% of the company’s shares, while institutions hold 13.54% stake in the company. Shares short for MBOT as of 1761868800 were 4350814 with a Short Ratio of 1.02, compared to 1759190400 on 4536820. Therefore, it implies a Short% of Shares Outstanding of 4350814 and a Short% of Float of 6.52.

Earnings Estimates

At present, 1.0 analysts are actively evaluating the performance of Microbot Medical Inc (MBOT) in the stock market.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.09 and low estimates of -$0.09.

Analysts are recommending an EPS of between -$0.31 and -$0.31 for the fiscal current year, implying an average EPS of -$0.31. EPS for the following year is -$0.35, with 1.0 analysts recommending between -$0.35 and -$0.35.

Revenue Estimates

For the next quarter, 1 analysts are estimating revenue of $500k. There is a high estimate of $500k for the next quarter, whereas the lowest estimate is $500k. Based on 1 analysts’ estimates, the company’s revenue will be $6.8M in the next fiscal year. The high estimate is $6.8M and the low estimate is $6.8M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.